Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP410471.RA65mQtxYVHdl9kJevoii2CtEORiRQvCSIPakq-lWFgvA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP410471.RA65mQtxYVHdl9kJevoii2CtEORiRQvCSIPakq-lWFgvA130_assertion type Assertion NP410471.RA65mQtxYVHdl9kJevoii2CtEORiRQvCSIPakq-lWFgvA130_head.
- NP410471.RA65mQtxYVHdl9kJevoii2CtEORiRQvCSIPakq-lWFgvA130_assertion description "[Anti-CD86 treatment inhibited polyclonal Ig and anti-SS-A antibody production of SLE B cells, suggesting the preferential involvement of CD86 in polyclonal antibody production.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP410471.RA65mQtxYVHdl9kJevoii2CtEORiRQvCSIPakq-lWFgvA130_provenance.
- NP410471.RA65mQtxYVHdl9kJevoii2CtEORiRQvCSIPakq-lWFgvA130_assertion evidence source_evidence_literature NP410471.RA65mQtxYVHdl9kJevoii2CtEORiRQvCSIPakq-lWFgvA130_provenance.
- NP410471.RA65mQtxYVHdl9kJevoii2CtEORiRQvCSIPakq-lWFgvA130_assertion SIO_000772 12673892 NP410471.RA65mQtxYVHdl9kJevoii2CtEORiRQvCSIPakq-lWFgvA130_provenance.
- NP410471.RA65mQtxYVHdl9kJevoii2CtEORiRQvCSIPakq-lWFgvA130_assertion wasDerivedFrom befree-20140225 NP410471.RA65mQtxYVHdl9kJevoii2CtEORiRQvCSIPakq-lWFgvA130_provenance.
- NP410471.RA65mQtxYVHdl9kJevoii2CtEORiRQvCSIPakq-lWFgvA130_assertion wasGeneratedBy ECO_0000203 NP410471.RA65mQtxYVHdl9kJevoii2CtEORiRQvCSIPakq-lWFgvA130_provenance.